Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Predicting Psoriatic Arthritis in Early Psoriasis
1
Mins
July 2025
Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce treatment…
Read more
1
Mins
29 Jul 2019
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in MTX-IR Patients with Rheumatoid Arthritis
Fractalkine (CX3CL1, designated as FKN hereafter) is the sole member of the CX3C chemokine family which leads to dual actions, chemotaxis, and cell…
2
Mins
29 Jul 2019
Comparative Effectiveness Research in Observational Settings: Evaluating Two New Methods to Analyse Response Rates
Observational studies are being used more frequently to compare drug effectiveness. Authors typically report the proportion of patients…
2
Mins
29 Jul 2019
Circulating T Cell Clones in Preclinical Phases of Rheumatoid Arthritis
The aetiopathogenesis of rheumatoid arthritis (RA) is only partially understood, but is believed to result from a multi-step process, whereby…
1
Mins
29 Jul 2019
Comparison of PAXgene and Tempus Whole Blood RNA Collection and Isolation Systems for the Quantification of Type I Interferon-Stimulated Gene Expression
Type I IFN have important roles in many paediatric and adult rheumatic diseases and are a new therapeutic target for which several anti-IFN treatments…
1
Mins
29 Jul 2019
Effects of Successive Switches to Different Biosimilars Infliximab on Immunogenicity in Chronic Inflammatory Diseases in Daily Clinical Practice
Immunogenicity constitutes an important concern since it is associated with lower clinical responses and more adverse events…
1
Mins
31 Jul 2018
Treating Rheumatoid Arthritis to Target: Is Low Disease Activity Good Enough?
Treat-to-target principles in rheumatoid arthritis (RA) are now widely recognised as effective in achieving optimal disease outcomes. This study examined…
2
Mins
31 Jul 2018
Physician Global Assessments for Disease Activity in Rheumatoid Arthritis Are All Over the Map!
There have been many studies about patient global assessments of disease activity in rheumatoid arthritis (RA) and how these differ from physician global…
1
Mins
31 Jul 2018
Linking Systemic Angiogenic Markers to Synovial Vascularisation in Rheumatoid Arthritis
The synovium is the primary site of the rheumatoid arthritis (RA)-related inflammatory process. One of the most noticeable signs of synovitis is the…
Loading posts...
« Previous
1
…
3
4
5
6
7
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View